• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于醋酸纤维素的固体分散体基质纳米颗粒中难溶性抗病毒药物的溶出度增强

Enhanced dissolution of poorly soluble antiviral drugs from nanoparticles of cellulose acetate based solid dispersion matrices.

作者信息

Mazumder Sonal, Dewangan Ashish Kumar, Pavurala Naresh

机构信息

Department of Chemical Engineering, Birla Institute of Science and Technology, Pilani, Rajasthan 333031, India.

Oak Ridge Associated Universities, Food and Drug Administration, Silver Spring, MD, USA.

出版信息

Asian J Pharm Sci. 2017 Nov;12(6):532-541. doi: 10.1016/j.ajps.2017.07.002. Epub 2017 Jul 8.

DOI:10.1016/j.ajps.2017.07.002
PMID:32104366
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7032198/
Abstract

Polysaccharide-based polymers were used to produce nanoparticles of poorly soluble antiviral drugs using a rapid precipitation process. The structure-property relationships of four novel cellulose acetate-based polymers were studied for their solubility enhancement of poorly soluble drugs. Particles were purified by dialysis, and dried powders were recovered after freeze-drying. The particle diameters were 150-200 nm. The target drug loading in the particles was 25 wt%, and the drug loading efficiencies were 80-96%. The effects of the formulation process and nanoparticle properties on drug solubility were investigated. All nanoparticles afforded increased solubility and faster release compared to pure drugs. Drug release was a function of the relative hydrophobicity (or solubility parameters) of the polymers.

摘要

基于多糖的聚合物被用于通过快速沉淀法制备难溶性抗病毒药物的纳米颗粒。研究了四种新型醋酸纤维素基聚合物的结构-性能关系,以提高难溶性药物的溶解度。颗粒通过透析纯化,并在冷冻干燥后回收干粉。粒径为150-200nm。颗粒中的目标载药量为25wt%,载药效率为80-96%。研究了制剂工艺和纳米颗粒性质对药物溶解度的影响。与纯药物相比,所有纳米颗粒都提高了溶解度并实现了更快的释放。药物释放是聚合物相对疏水性(或溶解度参数)的函数。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/708e/7032198/4d9521f713cc/ajps449-fig-0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/708e/7032198/7d47993de08c/ajps449-ga-5001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/708e/7032198/d41fbaea78d9/ajps449-fig-0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/708e/7032198/6f051d4b3638/ajps449-fig-0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/708e/7032198/9866c4a66a02/ajps449-fig-0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/708e/7032198/70ca519a87a5/ajps449-fig-0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/708e/7032198/01a70688ec8d/ajps449-fig-0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/708e/7032198/5ba1e2e2de17/ajps449-fig-0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/708e/7032198/4d9521f713cc/ajps449-fig-0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/708e/7032198/7d47993de08c/ajps449-ga-5001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/708e/7032198/d41fbaea78d9/ajps449-fig-0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/708e/7032198/6f051d4b3638/ajps449-fig-0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/708e/7032198/9866c4a66a02/ajps449-fig-0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/708e/7032198/70ca519a87a5/ajps449-fig-0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/708e/7032198/01a70688ec8d/ajps449-fig-0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/708e/7032198/5ba1e2e2de17/ajps449-fig-0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/708e/7032198/4d9521f713cc/ajps449-fig-0007.jpg

相似文献

1
Enhanced dissolution of poorly soluble antiviral drugs from nanoparticles of cellulose acetate based solid dispersion matrices.基于醋酸纤维素的固体分散体基质纳米颗粒中难溶性抗病毒药物的溶出度增强
Asian J Pharm Sci. 2017 Nov;12(6):532-541. doi: 10.1016/j.ajps.2017.07.002. Epub 2017 Jul 8.
2
Design and characterization of loratadine nanosuspension prepared by ultrasonic-assisted precipitation.超声辅助沉淀法制备氯雷他定纳米混悬剂的设计与表征。
Eur J Pharm Sci. 2018 Sep 15;122:94-104. doi: 10.1016/j.ejps.2018.06.010. Epub 2018 Jun 14.
3
Enhancement of the apparent solubility and bioavailability of Tadalafil nanoparticles via antisolvent precipitation.通过抗溶剂沉淀法提高他达拉非纳米粒子的表观溶解度和生物利用度。
Eur J Pharm Sci. 2019 Feb 1;128:222-231. doi: 10.1016/j.ejps.2018.12.005. Epub 2018 Dec 13.
4
Solubility enhancement of BCS Class II drug by solid phospholipid dispersions: Spray drying versus freeze-drying.固体脂质分散体提高 BCS Ⅱ类药物溶解度:喷雾干燥与冷冻干燥的比较。
Int J Pharm. 2015 Dec 30;496(2):382-91. doi: 10.1016/j.ijpharm.2015.10.029. Epub 2015 Oct 20.
5
Multidrug, Anti-HIV Amorphous Solid Dispersions: Nature and Mechanisms of Impacts of Drugs on Each Other's Solution Concentrations.多药抗 HIV 无定形固体分散体:药物间相互作用对各自溶液浓度影响的本质和机制。
Mol Pharm. 2017 Nov 6;14(11):3617-3627. doi: 10.1021/acs.molpharmaceut.7b00203. Epub 2017 Sep 25.
6
Hybrid nanocrystal-amorphous solid dispersions (HyNASDs) as alternative to ASDs for enhanced release of BCS Class II drugs.用于增强 BCS 类 II 药物释放的混合纳米晶-无定形固体分散体(HyNASDs)替代 ASDs。
Eur J Pharm Biopharm. 2019 Dec;145:12-26. doi: 10.1016/j.ejpb.2019.10.002. Epub 2019 Oct 14.
7
Molecular structure and impact of amorphization strategies on intrinsic dissolution of spray dried indomethacin.喷雾干燥吲哚美辛无定形策略的分子结构及对固有溶出度的影响。
Eur J Pharm Sci. 2019 Mar 1;129:1-9. doi: 10.1016/j.ejps.2018.12.010. Epub 2018 Dec 13.
8
A comparative study of spray-dried and freeze-dried hydrocortisone/polyvinyl pyrrolidone solid dispersions.喷雾干燥和冷冻干燥的氢化可的松/聚乙烯吡咯烷酮固体分散体的比较研究。
Drug Dev Ind Pharm. 2011 Oct;37(10):1141-9. doi: 10.3109/03639045.2011.562213. Epub 2011 May 26.
9
Physicochemical properties of tadalafil solid dispersions - Impact of polymer on the apparent solubility and dissolution rate of tadalafil.他达拉非固体分散体的物理化学性质——聚合物对他达拉非表观溶解度和溶出速率的影响。
Eur J Pharm Biopharm. 2015 Aug;94:106-15. doi: 10.1016/j.ejpb.2015.04.031. Epub 2015 May 19.
10
pH-independent dissolution enhancement for multiple poorly water-soluble drugs by nano-sized solid dispersions based on hydrophobic-hydrophilic conjugates.基于疏水亲水性轭合物的纳米固体分散体实现多种疏水性差的药物的 pH 无关溶解增强。
Drug Dev Ind Pharm. 2019 Mar;45(3):514-519. doi: 10.1080/03639045.2018.1562466. Epub 2019 Jan 24.

引用本文的文献

1
Regulating Tumor-Associated Macrophage Polarization by Cyclodextrin-Modified PLGA Nanoparticles Loaded with R848 for Treating Colon Cancer.环糊精修饰的负载R848的聚乳酸-羟基乙酸共聚物纳米颗粒调控肿瘤相关巨噬细胞极化用于治疗结肠癌
Int J Nanomedicine. 2024 Apr 17;19:3589-3605. doi: 10.2147/IJN.S450205. eCollection 2024.
2
Revolutionizing Antiviral Therapeutics: Unveiling Innovative Approaches for Enhanced Drug Efficacy.抗病毒治疗的革命:揭示增强药物疗效的创新方法。
Int J Nanomedicine. 2024 Mar 20;19:2889-2915. doi: 10.2147/IJN.S447721. eCollection 2024.
3
Nanoparticle Strategies to Improve the Delivery of Anticancer Drugs across the Blood-Brain Barrier to Treat Brain Tumors.

本文引用的文献

1
Synthesis and structure-property evaluation of cellulose ω-carboxyesters for amorphous solid dispersions.纤维素 ω-羧基酯的合成及结构-性能评价用于无定形固体分散体。
Carbohydr Polym. 2014 Jan 16;100:116-25. doi: 10.1016/j.carbpol.2012.11.049. Epub 2012 Nov 27.
2
Assessing the performance of amorphous solid dispersions.评估无定形固体分散体的性能。
J Pharm Sci. 2012 Apr;101(4):1355-77. doi: 10.1002/jps.23031. Epub 2011 Dec 27.
3
Controlling drug nanoparticle formation by rapid precipitation.通过快速沉淀控制药物纳米颗粒的形成。
改善抗癌药物通过血脑屏障递送以治疗脑肿瘤的纳米颗粒策略。
Pharmaceutics. 2023 Jun 23;15(7):1804. doi: 10.3390/pharmaceutics15071804.
4
Targeting Spike Glycoprotein S1 Mediated by NLRP3 Inflammasome Machinery and the Cytokine Releases in A549 Lung Epithelial Cells by Nanocurcumin.纳米姜黄素靶向NLRP3炎性小体机制介导的刺突糖蛋白S1以及A549肺上皮细胞中的细胞因子释放
Pharmaceuticals (Basel). 2023 Jun 9;16(6):862. doi: 10.3390/ph16060862.
5
Nano-based techniques: A revolutionary approach to prevent covid-19 and enhancing human awareness.基于纳米的技术:一种预防新冠病毒和提高人类认知的革命性方法。
J Drug Deliv Sci Technol. 2023 Sep;86:104567. doi: 10.1016/j.jddst.2023.104567. Epub 2023 May 14.
6
Current Trends and Prospects for Application of Green Synthesized Metal Nanoparticles in Cancer and COVID-19 Therapies.绿色合成金属纳米粒子在癌症和 COVID-19 治疗中的应用现状及展望。
Viruses. 2023 Mar 13;15(3):741. doi: 10.3390/v15030741.
7
Increase in Dissolution Rate of Zotepine via Nanomilling Process - Impact of Dried Nanocrystalline Suspensions on Bioavailability.纳米研磨工艺提高佐替平溶出度 - 干燥纳米晶混悬剂对生物利用度的影响。
AAPS PharmSciTech. 2021 Dec 14;23(1):20. doi: 10.1208/s12249-021-02172-x.
8
Reactive Nanoparticles Derived from Polysaccharide Phenyl Carbonates.多糖苯碳酸酯衍生的反应性纳米粒子。
Molecules. 2021 Jul 1;26(13):4026. doi: 10.3390/molecules26134026.
9
A proposed insight into the anti-viral potential of metallic nanoparticles against novel coronavirus disease-19 (COVID-19).关于金属纳米颗粒对新型冠状病毒病(COVID-19)抗病毒潜力的一种见解。
Bull Natl Res Cent. 2021;45(1):36. doi: 10.1186/s42269-021-00487-0. Epub 2021 Feb 5.
10
Recent Advancement in Nanotechnology-Based Drug Delivery System Against Viral Infections.基于纳米技术的药物输送系统在抗病毒感染方面的最新进展。
AAPS PharmSciTech. 2021 Jan 14;22(1):47. doi: 10.1208/s12249-020-01908-5.
Adv Drug Deliv Rev. 2011 May 30;63(6):417-26. doi: 10.1016/j.addr.2011.04.005. Epub 2011 Apr 30.
4
Development and in-vivo assessment of the bioavailability of oridonin solid dispersions by the gas anti-solvent technique.采用气体抗溶剂技术制备冬凌草甲素固体分散体及其体内生物利用度评价。
Int J Pharm. 2011 Jun 15;411(1-2):172-7. doi: 10.1016/j.ijpharm.2011.04.006. Epub 2011 Apr 12.
5
A pH-dilution method for estimation of biorelevant drug solubility along the gastrointestinal tract: application to physiologically based pharmacokinetic modeling.一种用于估计胃肠道生物相关药物溶解度的 pH 稀释法:在基于生理的药代动力学建模中的应用。
Mol Pharm. 2010 Oct 4;7(5):1516-26. doi: 10.1021/mp100157s. Epub 2010 Aug 17.
6
Polymeric micelles for oral drug delivery.聚合物胶束用于口服药物递送。
Eur J Pharm Biopharm. 2010 Oct;76(2):147-58. doi: 10.1016/j.ejpb.2010.06.007. Epub 2010 Jun 19.
7
Drug-polymer solubility and miscibility: Stability consideration and practical challenges in amorphous solid dispersion development.药物-聚合物的溶解度和混溶性:无定形固体分散体开发中的稳定性考虑和实际挑战。
J Pharm Sci. 2010 Jul;99(7):2941-7. doi: 10.1002/jps.22074.
8
Combination antiretroviral drugs in PLGA nanoparticle for HIV-1.PLGA 纳米粒中的联合抗逆转录病毒药物治疗 HIV-1。
BMC Infect Dis. 2009 Dec 9;9:198. doi: 10.1186/1471-2334-9-198.
9
Stabilization of the nitric oxide (NO) prodrugs and anticancer leads, PABA/NO and Double JS-K, through incorporation into PEG-protected nanoparticles.通过将前体药物和抗癌先导物 PABA/NO 和 Double JS-K 整合到聚乙二醇保护的纳米粒子中,实现其稳定。
Mol Pharm. 2010 Feb 1;7(1):291-8. doi: 10.1021/mp900245h.
10
Pure drug and polymer based nanotechnologies for the improved solubility, stability, bioavailability and targeting of anti-HIV drugs.用于提高抗 HIV 药物的溶解性、稳定性、生物利用度和靶向性的纯药物和聚合物基纳米技术。
Adv Drug Deliv Rev. 2010 Mar 18;62(4-5):491-502. doi: 10.1016/j.addr.2009.11.019. Epub 2009 Nov 18.